A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice
Clinical trial NCT06251986 · COMPLETED
Trial details
- NCT number
- NCT06251986
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-26
- Primary completion
- 2024-12-23
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.